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Systemic inflammation, coagulopathy, and acute
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thoracoabdominal aortic aneurysm repair
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Mitchell J. Cohen, MD,e Linda M. Reilly, MD,a and Jade S. Hiramoto, MD,a San Francisco, Calif
Objective: To characterize the inflammatory and coagulopathic response after endovascular thoracoabdominal aortic
aneurysm (TAAA) repair and to evaluate the effect of the response on postoperative renal function.
Methods: From July 2005 to June 2008, 42 patients underwent elective endovascular repair of a TAAA using custom designed
multi-branched stent-grafts at a single academic institution. Four patients were excluded from the analysis. White blood cell
count (WBC), platelet count, prothrombin time (PT), and creatinine were measured in all patients. In the last nine patients,
interleukin-6 (IL-6), protein C, Factor V, d-dimers, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) levels
were also measured. Change in lab values were expressed as a percentage of baseline values.
Results: The 30-day mortality rate was 5% (2/38). All patients (n 38) had a higher WBC (mean SD: 139 80%, P<
.0001), lower platelet count (56  15%, P < .0001), and higher PT (median: 17%, Interquartile range (IQR) 12%-22%,
P < .0001) after stent-graft insertion. Twelve of 38 patients (32%) developed postoperative acute renal insufficiency
(>50% rise in creatinine). Patients with renal insufficiency had significantly larger changes inWBC (178 100% vs 121
64%, P  .04) and platelet count (64  17% vs 52  12%, P  .02) compared with those without renal insufficiency. All
patients (n 9) had significant increases in NGAL (182 115%, P .008) after stent-graft insertion. Six of nine patients
(67%) had increased cystatin C (35  43%, P  .04) after stent-graft insertion, with a greater rise in those with
postoperative renal insufficiency (87 32% vs 8 13%, P .02). IL-6 levels were markedly increased in all patients (n
9) after repair (9840 6160%, P .008). Protein C (35 10%, P .008) and Factor V levels (28 20%, P .008) were
uniformly decreased, while d-dimers were elevated after repair in all patients (310  213%, P  .008).
Conclusions: Leukocytosis and thrombocytopenia were uniform following endovascular TAAA repair, and the severity of
the response correlated with post-operative renal dysfunction. Elevation of a sensitive marker of renal injury (NGAL)
suggests that renal injury may occur in all patients after stent-graft insertion. (J Vasc Surg 2009;49:1140-6.)Thoracoabdominal aortic aneurysm (TAAA) is a lethal
disease if left untreated.1 Open surgical repair is associated
with high morbidity and mortality rates. Statewide audits
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1140show 30-day mortality rates of 20% and one-year mortality
rates of approximately 30%.2 Endovascular TAAA repair is
an alternative approach, whereby the components of a
multi-branched stent-graft are inserted entirely through
the femoral and brachial arteries, and assembled within the
thoracoabdominal aorta.3 Short term results following en-
dovascular TAAA repair in high risk patients demonstrate
lower morbidity and mortality rates compared with the
traditional open approach.4,5
Despite the potential benefits of endovascular treat-
ment of aortic aneurysms,6,7 almost all patients who un-
dergo placement of an aortic stent-graft experience a sys-
temic response termed the post-implantation syndrome.8
This is characterized by fever, anorexia, elevated white
blood cell count (WBC), and changes in coagulation pa-
rameters.8-13 For less extensive aneurysm repair, such as
endovascular abdominal aortic aneurysm (AAA), the syn-
drome typically resolves within two weeks without any
permanent ill effects. Rarely, it results in severe complica-
tions such as pulmonary dysfunction, cardiovascular events,
renal insufficiency, andmulti-system organ failure.13,14 Lit-
tle is known about the pathophysiology or mechanisms
underlying this response. Possible causes include injury to
the vascular endothelium, manipulation of thrombus in the
aneurysm, or platelet activation by the graft material.
Considering the greater extent of diseased aorta, high
complexity of repair, and long length of stent-graft im-
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that endovascular TAAA repair triggers a severe form of the
post-implantation syndrome. Moreover, inflammatory cy-
tokines, disordered coagulation, and leukocyte-endothelial
interactions have been suggested to play important roles in
the pathogenesis of acute kidney injury.15 The purpose of
this study is to characterize the inflammatory, coagulo-
pathic, and renal response after endovascular TAAA repair.
METHODS
Patients
Between July 2005 and June 2008, 42 patients under-
went endovascular TAAA repair using custom-designed
modular multi-branched stent-grafts (Fig 1) at the Univer-
sity of California-San Francisco Medical Center. All of the
branched endografts were made of Dacron and stainless
steel (Cook Medical Inc., Bloomington, Ind). Each cuff is
then bridged by a Fluency covered stent (Polytetrafluoro-
ethylene and nitinol, C.R. Bard Inc., Tempe, Ariz) into the
target vessel, and then a Wallstent (Elgiloy, Boston Scien-
tific Corp., Natick, Mass) is placed. All procedures were
performed under a physician-sponsored Investigational
Device Exemption from the United States Food and Drug
Administration (FDA), with the approval of the local Insti-
Fig 1. Computed tomographic angiography with three-
dimensional reconstruction after multi-branched endovascular
thoracoabdominal aortic aneurysm (TAAA) repair.tutional Review Board. The inclusion and exclusion criteriafor endovascular TAAA repair have previously been pub-
lished.5 Of the 42 patients who underwent endovascular
TAAA repair, four patients were excluded from the analysis.
Two patients were excluded due to pre-existing end stage
renal disease requiring dialysis. One patient was excluded
because of a fatal anesthetic complication, and one patient
was excluded because he underwent another significant
operation at the time of aneurysm repair.
Patient demographics and follow-up
Patient demographic information, including age, gen-
der, aneurysm size, pre-operative medications, and medical
co-morbidities were collected prospectively. Data on pre-
existing co-morbidities were collected from patients’ self-
reported history and focused on coronary artery disease
(CAD), hypertension, diabetes mellitus, peripheral vascular
disease, cerebrovascular disease, and prior aortic surgery
(Table I). Pre-operative use of aspirin, plavix, coumadin,
hypertensive medications, andHMG-CoA reductase inhib-
itors (statins) were recorded at the initial clinic visit.
Anatomic characteristics of the TAAA (aneurysm size
and extent), intraoperative procedural details, laboratory
data, and postoperative outcomes were all collected pro-
spectively. Percentage of aortic coverage was defined as the
length of aorta covered by the stent-graft divided by the
total length of the thoracoabdominal aorta from the origin
of the left subclavian artery to the iliac bifurcation. All
patients were admitted to the hospital one day prior to the
procedure. If the glomerular filtration rate (GFR) calcu-
lated by the Modification of Diet in Renal Disease
(MDRD) equation was less than 60 mL/min/1.73 m2,16
patients were administered an intravenous bicarbonate in-
fusion and given an oral dose of 600 mg of N-acetylcyste-
ine. All patients received Visipaque contrast during endo-
Table I. Patient characteristics and operative details
Patient demographics n  38
Age (yrs, mean  SD) 75.1  7.3
Male (no) 29 (76%)
Patient comorbidities
Hypertension 34 (89%)
Diabetes 6 (16%)
Coronary artery disease 21 (55%)
Cerebrovascular disease 9 (24%)
Peripheral vascular disease 11 (29%)
Prior aortic surgery 18 (47%)
Preoperative statin use 28 (74%)
Baseline creatinine (mg/dL) 1.25  0.36
Baseline GFR (mL/min/1.73 m2) 62.3  20.6
Maximum aneurysm size 67  10
Operative details
Operative time (hrs) 6.8  1.9
Percent aortic coverage (%) 69  19
Transfusion during surgery 22 (58%)
General anesthesia 26 (68%)
GFR, Glomular filtration rate.
Continuous data are presented as means standard deviation except where
noted.
Categorical data are given as counts (percentages).vascular TAAA repair.
JOURNAL OF VASCULAR SURGERY
May 20091142 Chang et alAll patients underwent postoperative computed-tomo-
graphic angiography (CTA) prior to discharge. Follow up
clinical assessment, CTA, and creatinine measurement were
performed at one, six, and 12 months, and then yearly
thereafter.
Laboratory measurements
WBC, platelet count, prothrombin time (PT), and
serum creatinine were collected the day before endovascu-
lar repair, immediately postoperatively, and then daily until
discharge. In the last nine patients, additional serum mark-
ers of inflammation (interleukin-6 [IL-6]), coagulation
(protein C, factor Va, d-dimer), renal injury (renal gelati-
nase-associated lipocalin [NGAL]), and renal function
(cystatin C) were collected preoperatively, postoperatively,
and for the first three days following surgery.
Analytical assays
Serum marker of inflammation. IL-6 levels were
quantified using enzyme-linked immunosorbent assay
(ELISA) assays (Biosource, Carlsbad, Calif). Blood samples
were collected, allowed to clot, and centrifuged at 1000g to
isolate serum in serum separator tubes (BD Biosciences,
Franklin Lakes, NJ). Control blood samples were collected
at a single time point and processed as described above. The
serum samples were stored at 20°C until ELISA assays
were performed according to manufacturer’s instructions.
Concentrated samples were diluted up to five-fold. Stan-
dards, samples, and controls were run in duplicates and read
at 450 nm (Tecan, San Jose, Calif). IL-6 concentrations
(pg/mL) were then calculated based on constructed stan-
dard curves.
Serummarkers of coagulation. Protein C, factor Va,
and d-dimer levels were measured with the Stago STA-
Compact coagulation analyzer (Diagnostica STAGO, Inc,
Parsippany, NJ).
Serum markers of renal injury and function. Quan-
titative NGAL levels were measured using an ELISA sand-
wich immunoassay (R&D Systems, Minneapolis, Minn)
and performed according to manufacturer’s instructions.
Concentrated samples were diluted up to five-fold with
manufacturer-provided diluent. Standards, samples, and
controls were run in duplicates and the resulting chroma-
gen was read at 450 nm with an additional 570 nm wave-
length correction (Tecan). NGAL concentrations (ng/
mL) were then calculated based on the constructed
standard curves on respective ELISA plates. Cystatin C was
measured using a particle-enhanced immunonephelomet-
ric assay (N Latex Cystatin C, Dade Behring, Inc, Deer-
field, Ill) with a nephelometer (BNII, Dade Behring, Inc).
Definitions and measurements
Acute renal insufficiency was defined as a 50% or greater
rise in serum creatinine compared with baseline values.
Changes in serum creatinine, WBC, PT, platelet count,
NGAL, IL-6, cystatin C, protein C, Factor V, and d-dimer
levels were calculated as the differences between peak (or
nadir) postoperative values and baseline (preoperative)concentrations. Peak and nadir values were defined as the
highest and lowest values, respectively, within the first five
postoperative days. This limitation was applied in order to
restrict the analysis to the postoperative systemic response
and avoid changes in laboratory values resulting from later
complications. Estimated GFR was determined by the
MDRD study equation.16
Statistical analysis
All statistical analysis was performed using STATA 9.0
software (StataCorp, College Station, Tex). Continuous
variables are expressed as a mean  standard deviation for
normally distributed variables and compared using the
Student’s t test. The paired t test was used to compare
baseline and peak values for each patient. Continuous
variables with a skewed distribution are expressed as a
median and interquartile range and compared using the
Wilcoxon rank sum test or sign rank test. The Chi-square
test was used to compare categorical variables. Statistical
significance was inferred at P  .05.
Univariate logistic regression analysis was used to eval-
uate the association between postoperative acute renal in-
sufficiency and various predictors. Model checks included
specification testing and the Hosmer-Lemeshow goodness
of fit tests. In addition, univariate linear regression analysis
was used to assess the association between absolute change
in creatinine and various predictors.
RESULTS
All patients (n  38) underwent successful endovascu-
lar TAAA repair. Patient demographics and operative de-
tails are shown in Table I. Mean patient age was 75.1 7.3
years (range, 57.8 to 86.5 years) and 29/38 (76%) were
men. Thirty day mortality following endovascular TAAA
repair was 5% (2/38 patients). Eighteen of 38 patients
(47%) developed a fever (temperature  38.0 °C) during
the postoperative period. The mean contrast dose admin-
istered during endovascular TAAA repair was 170 85mL
(range, 28 to 390 mL).
Patients (n 38) had statistically significant changes in
WBC, platelet count, and PT following endovascular
TAAA repair (Table II). Every patient had a higher WBC
(mean SD: 139 80%; range, 10% to 390%) at a median
time of one day after repair; a lower platelet count (mean
SD: 56  15%; range, 26% to 87%) at a median time of
three days after repair; and a higher PT (median 17%; range:
4 to 175%) at a median time of two days after repair.
Preoperative statin use was associated with reduced periop-
erative changes in WBC (118  52% vs 198  114%, P 
.005), but not in platelet count or PT. The magnitude of
the changes in WBC, platelet count, and PT did not corre-
late with aneurysm size, extent of aortic coverage, contrast
dose, length of operation, postoperative fever, or presence
of postoperative endoleak (P  .05 for all associations).
The mean baseline GFR was 62  21 mL/min/1.73
m2 in our cohort of patients and decreased to 46  23
mL/min/1.73 m2 after repair (P .0001). After endovas-
cular TAAA repair, the mean baseline creatinine increased
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.0001) (Table II). Twelve of 38 patients (32%) developed
postoperative acute renal insufficiency. Patients with renal
insufficiency had larger changes in WBC (178  100% vs
121 64%, P .04) and platelet count (64 17% vs 52
12%, P  .02) compared with those who did not develop
renal insufficiency in the postoperative period (Fig 2).
There was no significant increase in PT amongst those with
postoperative renal insufficiency (median PT, 20; IQR,
15%-30%) compared with those without renal insufficiency
(median PT, 15; IQR, 11%-21%, P  .09). Preoperative
GFR  60 mL/min/1.73 m2 was not associated with the
development of acute renal insufficiency (P  .80). The
two patients who died within 30 days in our series both
developed acute renal insufficiency in the early postopera-
tive period.
Univariate logistic regression analysis demonstrated
that each 5  109 cells/liter increase in WBC in the
postoperative period was associated with a 2.4-fold odds of
postoperative renal insufficiency (P  .02; 95% CI, 1.2-
4.9). Each 50  109 cells/liter decrease in platelet count
was associated with a 4.0-fold odds of postoperative renal
Table II. Perioperative WBC, platelet count, PT, creatinin
Baseline Peak o
WBC 6.9  1.4 16.6
Platelets 206  67 89
PT 13.7 (12.5-14.4) 16.6 (1
Creatinine 1.25  0.36 1.89
GFR 62  21 46
GFR, Glomular filtration rate; PT, prothrombin time; WBC, white blood c
WBC and platelets: X 109 cells/liter; PT: seconds; Creatinine: mg/dL; GF
aPaired t test.
bWilcoxon signed rank test.
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increases in cystatin C levels after TAAA repair. Mean
cystatin C levels were significantly elevated post-operatively
(35 43%, P .04, Fig 4, B), and the rise in cystatin C was
greater in patients with postoperative acute renal insuffi-
ciency compared with those with no change in renal func-
tion (87  32% vs 8  13%, P  .02).
IL-6 levels were markedly elevated in all patients
(mean  SD: 9,840  6,160%, P  .003) following
endovascular repair (Fig 5). Protein C (35  10%, P 
.008) and Factor V levels (28  20%, P  .008) were
uniformly decreased, while d-dimers were elevated in all
patients after repair (310  213%, P  .008) (Fig 6).
DISCUSSION
Endovascular repair of TAAA results in significant leu-
kocytosis and thrombocytopenia, which appear to be re-
lated to postoperative acute renal insufficiency. The inflam-
matory sequelae may not amount to much after endovascular
AAA repair, but they constitute a significant source of mor-
bidity after endovascular TAAA repair. In our previous
report on the results of multi-branched endovascular
TAAA repair, the hemorrhagic complications of thrombo-
cytopenia and coagulopathy included upper gastrointesti-
nal bleeding, hemoptysis, and subarachnoid hemorrhage.5
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mentation of the endothelium, the presence of a stent-
graft, or thrombosis of the aneurysm. For example, some
authors suggest that manipulation in the aneurysm during
endovascular repair may cause white cell activation with the
release of various cytokines, such as IL-1, IL-6, and TNF-,
while others suggest that injury to the vascular endothe-
liummay prompt activation of protein C, with a subsequent
coagulopathy and loss of cytoprotectivity.13-14,17,18 Our
data on endovascular TAAA repair are helpful in this regard
because the inflammatory response is pronounced and con-
sistent, occurring in every single patient treated. Moreover,
there were strong correlations between inflammatory, he-
matologic, and renal effects, suggesting that causal rela-
tionships connect them all, although we cannot yet say
how. All patients in our study had markedly elevated levels
of IL-6 and a two-fold increase in WBC after stent-graft
implantation, suggesting a strong inflammatory response.
In addition, the coagulopathic response was characterized
by a decrease in protein C levels immediately after endovas-
cular repair, followed by a significant drop in platelet count
and increase in prothrombin time.
It seems likely that the inflammatory response caused
the renal dysfunction, rather than the converse. Other
possible explanations for a high rate of postoperative renal
dysfunction in this study group include contrast nephro-
toxicity and intraoperative ischemia. All of the patients in
this study received Visipaque contrast. The mean contrast
volume used during repair was 170 mL, with a range of 28
to 390 mL. Of note, the only patient who left the hospital
on dialysis was the one who received the smallest dye load
(28 mL). There is no period of obligatory renal ischemia
during endovascular TAAA repair. Blood flows through the
cuffs of the stent-graft into the peri-graft space, and from
there into the renal and visceral arteries. In theory, the
interruption of flow to a branch vessel would only be
occluded for as long as it took to deploy the Fluency
covered stent, or to inflate a balloon within the covered
stent or the outflow artery. Based on the tapered shape of
the stent-graft and the method of insertion, we believe
renal ischemia occurred rarely, if ever.
We recognize that alterations in serum creatinine are
not necessarily the most reliable basis for an assessment of
renal function. In the latter part of this study, we started to
measure novel biomarkers of renal function (cystatin C)
and renal tubular injury (NGAL).19,20 Cystatin C has
emerged as an important marker of acute renal dysfunction,
and appears to correlate better with GFR than serum cre-
atinine.21-24 NGAL, an indicator of acute tubular injury,
may also have a role in establishing the precise timing of
renal injury,25 as we try to establish a chain of events in the
interplay of the inflammatory, coagulopathic, and renal
effects.
Most of the theories regarding the etiology of the
post-implantation syndrome fall into one of two groups:
those that depend on catheter-mediated injury, and those
that depend on the presence of the stent graft. Since the
implantation of a branched stent graft consists largely of aseries of intra-arterial catheter manipulations, the duration
of the operation may serve a surrogate for the extent of
aortic instrumentation. Our surrogates for aneurysm and
stent-graft related effects were the extent of aortic coverage
and aneurysm diameter. None of these factors correlated
with the inflammatory response. The only significant deter-
minant of the extent of the inflammatory response was
statin use, with a significantly less pronounced leukocytosis
in those taking any form of statin therapy. If anyone needs
yet another reason to promote routine statin use in vascular
surgery patients, here it is.
The results of endovascular TAAA repair compare well
with the results of open surgical repair, but the outcomes
are marred by the effects of a severe inflammatory re-
sponse.5 Not that this response is unique to endovascular
repair of TAAA; some manifestations of the post-implan-
tation syndrome occur in all patients who undergo en-
dovascular treatment of aortic diseases (abdominal aortic
aneurysms, thoracic aneurysms, and thoracic dissec-
tions).9,13,26-28 However, those undergoing endovascular
TAAA repair appear to experience a more extreme re-
sponse. As we have learned to overcome the technical
obstacles to stent-graft insertion, the post-implantation
syndrome has become the main impediment to an uncom-
plicated postoperative course.
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